4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2013 / Randomized controlled trial
In a trial of 56 patients with coronary artery disease, participants received garlic powder tablets or placebo twice daily for 3 months. Garlic resulted in minor intima-media thickness variation (-0.009 ± 0.007 mm), whereas placebo showed an increase (0.04 ± 0.01 mm), reflecting a significant between-group divergence (p < 0.001). Lipid and lipoprotein concentrations did not differ significantly between treatments.
Mahdavi-Roshan M, Zahedmehr A, Mohammad-Zadeh A, et al. Nutr Health, 2013. PMID 25573347
2012 / Randomized controlled trial
A randomized trial in 117 car battery industry workers evaluated garlic (1200 μg allicin three times daily) versus d-penicillamine (250 mg three times daily) for four weeks. Blood lead concentrations dropped significantly in both the garlic group (426.32 to 347.34 μg/L, p=0.002) and d-penicillamine group (417.47 to 315.76 μg/L, p=0.025), without differing significantly between groups. Garlic also improved symptoms such as headaches, irritability, deep tendon reflexes, and systolic blood pressure, while causing significantly fewer side effects than d-penicillamine (p=0.023).
Kianoush S, Balali-Mood M, Mousavi SR, et al. Basic Clin Pharmacol Toxicol, 2012. PMID 22151785
2012 / Masked factorial randomized placebo-controlled trial
Participants were tracked for 14.7 years following interventions in the Shandong Intervention Trial. Long-term supplementation with garlic or vitamins (C, E, and selenium) was linked to non-statistically significant decreases in gastric cancer incidence and mortality. However, vitamin supplementation significantly lowered combined deaths from gastric or esophageal cancer (hazard ratio = 0.51, 95% CI = 0.30 to 0.87; P = .014).
Ma JL, Zhang L, Brown LM, et al. J Natl Cancer Inst, 2012. PMID 22271764
2001 / Randomized controlled trial
In a 12-week trial, 146 volunteers took either an allicin-containing garlic pill or a placebo daily. Participants receiving garlic experienced significantly fewer colds than those on placebo (24 versus 65, P < .001). The garlic group also recorded fewer total days with viral illness (111 versus 366, P < .05) and shorter average symptom duration (1.52 versus 5.01 days, P < .001).
Josling P Adv Ther, 2001. PMID 11697022
1990 / Intervention trial with repeated testing on different days
Volunteers received intragastric infusions of ginger (2, 4, 6 g) and garlic (0.3, 0.75, 1.5, 3 g uncooked; 3 g cooked) on separate days to assess changes in gastric aspirate DNA content. Infusion of 2 g and 4 g ginger led to non-significant changes, while 6 g ginger significantly increased DNA-p/min by 3.23 +/- 1.02 (P < 0.05). Uncooked garlic at 0.3 g had no significant effect, but doses of 0.75, 1.5, and 3 g significantly increased DNA-p/min by 5.47 +/- 1.63 (P < 0.01), 10.42 +/- 3.46 (P < 0.01), and 29.26 +/- 4.55 (P < 0.001), respectively. Infusion of 3 g cooked garlic also significantly increased DNA-p/min by 21.43 +/- 4.62 (P < 0.001), with no significant difference between cooked and uncooked 3 g garlic.
Desai HG, Kalro RH, Choksi AP Indian J Med Res, 1990. PMID 2370094